West Chester, PA – Monday, June 6th, 2022 /OrthoSpineNews/ – Altus Spine, a leader in the development and innovation of medical devices used in spinal correction surgery, announces Platinum Level Sponsorship of the Society of University Neurosurgeons Annual Meeting, being held June 29th-July 3rd, 2022. Located in the heart of Europe in Prague, Czech Republic, the SUN meeting will take place at The Hilton Hotel Old Town, conveniently located right in the historical center of the city.
The five-day meeting will take the members of the SUN Society and their guests through an extremely valuable scientific program on current topics relating to the practice of spine and neurosurgery.
This highest level of sponsorship exhibits Altus Spine’s commitment to supporting crucial educational programs for spine fellows and surgeons.
“The Society of University Neurosurgeons Annual Meeting is a highly interactive scientific program designed to inform the attendees of new trends and innovative topics in the neuro and spine community,” said Michael Fitzgerald, President and CEO. “Altus Spine is thrilled to be one of the lead sponsors of this program and have the opportunity to not only educate leading surgeons, but to also familiarize attendees with our innovative portfolio of solutions for spinal complications,” said Fitzgerald.
Altus Spine will be exhibiting an array of their innovative portfolio at the event including: Le Forte Neuro Plating System, Fuji Cervical Plate System, Suzuka Cervical IBF System, Sochi OCT System, and the Interlagos Retractor System. In addition, the team will be introducing their Monaco HA Pedicle Screw System, featuring their low-profile screw system with hydroxyapatite (HA) coating over the entire thread length, intended to enhance fixation between the pedicle screw and surrounding bone.
For more information, contact us at firstname.lastname@example.org
Based in West Chester, PA, Altus Spine is dedicated to creating the next generation of medical devices. Altus strives to improve patient care by designing and manufacturing products to meet the highest standards in an ever changing and evolving field. Implemented and used by over 100 hospitals across the United States, Altus is among the fastest growing spinal implant companies in the world. For additional information, or to inquire about distribution opportunities, please contact us at email@example.com.
Forward Looking Statements
All statements made in the above press release, with the exception of historical fact, may be forward-looking statements that include risk, uncertainty, and assumptions. These factors could cause Altus Spine’s results to differ from those predicted if they do not occur as expected. These uncertain factors include, but are not limited to: acceptance and clearance of the company’s surgical products and procedures, development of new products and procedures, innovations and alterations to existing products and procedures, clinical and statistical verification of the success using Altus Spine’s products, company’s ability to maintain and monitor inventory as it releases new products, its ability to hire and retain personnel, and any other risks stated in prior or subsequent news releases. All risks and potential complications can be found in our most recent 510(k) report from the Food and Drug Administration (FDA). Given the constantly changing market, readers are encouraged to not place undue reliance on forward-looking statements. Altus Spine assumes no obligation to update forward-looking statements as these changes occur, or as events and circumstances are altered, after the date they are posted.